Dr. Uday R. Popat
Claim this profileM D Anderson Cancer Center
Studies Acute Myeloid Leukemia
Studies Myelodysplastic Syndrome
9 reported clinical trials
18 drugs studied
Area of expertise
1Acute Myeloid Leukemia
HLA positive
HLA negative
FLT3 negative
2Myelodysplastic Syndrome
p53 positive
CBL positive
NRAS positive
Affiliated Hospitals
Clinical Trials Uday R. Popat is currently running
Venetoclax + Chemotherapy
for AML and MDS
This phase II trial studies the effect of venetoclax together with busulfan, cladribine, and fludarabine in treating patients with high-risk acute myeloid leukemia or myelodysplastic syndrome who are undergoing stem cell transplant. Chemotherapy drugs, such as venetoclax, busulfan, cladribine, and fludarabine, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Adding venetoclax to the current standard of care stem cell transplant regimen of busulfan, fludarabine, and cladribine may help to control high-risk acute myeloid leukemia or myelodysplastic syndrome.
Recruiting1 award Phase 2 & 323 criteria
Ruxolitinib + Stem Cell Transplant
for Myelofibrosis
To learn if giving ruxolitinib and busulfan before a stem cell transplant can help to reduce spleen size and help the transplant to succeed.
Recruiting1 award Phase 2
More about Uday R. Popat
Clinical Trial Related8 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Uday R. Popat has experience with
- Busulfan
- Fludarabine Phosphate
- Cladribine
- Venetoclax
- Allogeneic Stem Cell Transplantation
- Ruxolitinib
Breakdown of trials Uday R. Popat has run
Acute Myeloid Leukemia
Myelodysplastic Syndrome
Acute Myelogenous Leukemia
Acute Lymphoblastic Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Uday R. Popat specialize in?
Uday R. Popat focuses on Acute Myeloid Leukemia and Myelodysplastic Syndrome. In particular, much of their work with Acute Myeloid Leukemia has involved HLA positive patients, or patients who are HLA negative.
Is Uday R. Popat currently recruiting for clinical trials?
Yes, Uday R. Popat is currently recruiting for 3 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Uday R. Popat has studied deeply?
Yes, Uday R. Popat has studied treatments such as Busulfan, Fludarabine Phosphate, Cladribine.
What is the best way to schedule an appointment with Uday R. Popat?
Apply for one of the trials that Uday R. Popat is conducting.
What is the office address of Uday R. Popat?
The office of Uday R. Popat is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.